TXLNG expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.273800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.837200E-01
Normal-vs-Stage2
3.086600E-01
Normal-vs-Stage3
1.853370E-01
Normal-vs-Stage4
6.850000E-01
Stage1-vs-Stage2
8.204000E-02
Stage1-vs-Stage3
2.554000E-02
Stage1-vs-Stage4
6.430400E-01
Stage2-vs-Stage3
1.673610E-01
Stage2-vs-Stage4
4.487700E-02
Stage3-vs-Stage4
2.403900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.887600E-01
Normal-vs-AfricanAmerican
9.562600E-01
Normal-vs-Asian
3.903000E-01
Caucasian-vs-AfricanAmerican
1.743050E-01
Caucasian-vs-Asian
6.400600E-01
AfricanAmerican-vs-Asian
2.742600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.648600E-01
Normal-vs-Female
7.103400E-01
Male-vs-Female
2.236500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.435800E-01
Normal-vs-Age(41-60Yrs)
7.675000E-01
Normal-vs-Age(61-80Yrs)
1.465230E-01
Normal-vs-Age(81-100Yrs)
1.344050E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.535600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.905240E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.169000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.301300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.163800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.864600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.277000E-01
Normal-vs-Daily Drinker
2.264800E-01
Normal-vs-Weekly Drinker
2.328000E-01
Normal-vs-Occasional Drinker
5.589000E-01
Normal-vs-Social Drinker
8.657000E-01
Non Drinker-vs-Daily Drinker
7.949200E-01
Non Drinker-vs-Weekly Drinker
8.641200E-01
Non Drinker-vs-Occasional Drinker
2.765400E-01
Non Drinker-vs-Social Drinker
1.756620E-01
Daily Drinker-vs-Weekly Drinker
9.518800E-01
Daily Drinker-vs-Occasional Drinker
2.311200E-01
Daily Drinker-vs-Social Drinker
1.136230E-01
Weekly Drinker-vs-Occasional Drinker
2.903600E-01
Weekly Drinker-vs-Social Drinker
1.709210E-01
Occasional Drinker-vs-Social Drinker
5.606600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.261580E-01
Normal-vs-Grade 2
5.496000E-02
Normal-vs-Grade 3
4.373800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.591800E-01
Grade 1-vs-Grade 3
5.205800E-01
Grade 1-vs-Grade 4
1.261580E-01
Grade 2-vs-Grade 3
6.042000E-01
Grade 2-vs-Grade 4
5.496000E-02
Grade 3-vs-Grade 4
4.373800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.730400E-01
Normal-vs-NonDiabetic
3.311800E-01
Diabetic-vs-NonDiabetic
1.768770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.436200E-01
Normal-vs-NoPancreatitis
2.586800E-01
Pancreatitis-vs-NoPancreatitis
3.503400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.380800E-01
Normal-vs-N1
2.935400E-01
N0-vs-N1
5.874000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.185800E-01
Normal-vs-TP53-NonMutant
7.287800E-01
TP53-Mutant-vs-TP53-NonMutant
4.375200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
